Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human lifespan
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
Sam Altman predicts artificial superintelligence (AGI) will happen this year
Alan Thompson, an expert in artificial intelligence and former chairman of Mensa International, runs the Conservative ...
Sam Altman says the kid he’s expecting soon will never be smarter than AI, but thinks this ability will be valuable
"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird ...
eWeek3d
Sam Altman’s AI Briefing: Super-Agents To Revolutionize Software, Finance, and More
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...